Feb 29 (Reuters) – The U.S. Food and Drug Administration on Monday unveiled new measures to evaluate the risk of Bayer AG’s implantable steralization device, Essure, following patient complaints and…
The post FDA asks for more tests on Essure to evaluate risk appeared first on NASDAQ.